GL1X · GenesisL1 explorer

Research workbench

The structure of BCL6 btb (poz) domain in complex with the ansamycin antibiotic rifabutin.

Analyse The structure of BCL6 btb (poz) domain in complex with the ansamycin antibiotic… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4CP3
Type
protein
Length
244 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
B-cell lymphoma 6 protein
UniProt
P41182
Ligands
RBT
Pockets
2 · best druggability 0.46

Structure

x-ray diffraction · 2 distinct chains · 53% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AB-cell lymphoma 6 proteinprotein12254% helix, 15% strandP41182
BB-cell lymphoma 6 proteinprotein12252% helix, 15% strandP41182

Ligands and binding sites

  • RBT · Rifabutin · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11500.460.7624empty
21460.450.7624empty

Interfaces

1 interface between chains.

  • A–B · 1755 Ų buried · 18 hydrogen bonds · protein-protein

Compared structures

  • 4CP3 · The structure of BCL6 BTB (POZ) domain in complex with the ansamycin antibiotic rifabutin. · the same entry in another collection · chain A against A, TM-score 1.00
  • P41182 · AlphaFold monomer V2.0 prediction for B-cell lymphoma 6 protein (P41182) · a predicted model of the same protein · chain B against A, TM-score 0.34

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.